How can I explain depressor anguli oris (DAO) botulinum toxin (Botox) injection to a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DAO (Depressor Anguli Oris) Botox: How I explain it to patients

DAO Botox safely relaxes the small muscle that pulls your mouth corners down, subtly lifting them for a less “sad” or tired look with low risk when placed precisely. 1, 2

  • What it does

    • The DAO pulls the mouth corners downward; tiny doses of botulinum toxin A weaken it, allowing elevators to lift the corner slightly (a “mouth-corner lift”) and soften marionette-line tension. Expect a natural, not “frozen,” change. 1
  • What you’ll notice and when

    • Onset: 3–7 days; peak around 2 weeks; lasts about 3–4 months. Small lift in the corner of the mouth and a less downturned, less displeased resting expression. 1
    • Evidence note: Lower (more inferior) DAO injection points lift more effectively than higher points, and adding select platysma points can further improve corner position in some cases, with minimal added risk. 3
  • How we inject (precise and safe)

    • One intramuscular point per side, just lateral to the marionette line/labiomandibular fold, kept within a “safe zone” to avoid the depressor labii inferioris (which would drop the lower lip if hit). Typical total dose ≈ 5–6 units split across both sides. 1
    • Ultrasound guidance improves accuracy because DAO position varies among people; it helps avoid neighboring muscles and improves predictability. I recommend it. 4, 2
  • Benefits for morbidity, mortality, and quality of life

    • Primary benefit is quality of life: softens a displeased look that can affect social interactions and self-perception; trials show objective mouth-corner elevation and higher satisfaction when optimal sites (lower DAO, ± platysma) are used. 3
    • No mortality or major morbidity impact in healthy cosmetic patients when performed correctly; safety hinges on precise placement. 1
  • Risks and how we minimize them

    • Most common: temporary weakness where treated; potential asymmetry, smile changes, or mild speech/chew changes if toxin spreads.
    • Key pitfall: Hitting the depressor labii inferioris can cause lower-lip inversion/asymmetry. We avoid this by staying lateral to the marionette line, using low doses, and favoring lower DAO targeting; ultrasound further reduces this risk. 1, 4, 2
    • Severe botulism-like effects are extraordinarily rare with cosmetic dosing; systemic toxicity guidance exists for iatrogenic botulism, but this pertains to high-dose therapeutic/accidental exposures, not standard cosmetic DAO treatment. 5
  • What to expect on the day

    • Few tiny injections; minimal discomfort; no anesthesia needed. Small bumps or bruises can occur and resolve quickly. Avoid rubbing the area, strenuous exercise, or face-down massage for 4–6 hours.
  • When we might add the neck (platysma)

    • If the corner downturn is partly from neck bands/jawline pull, adding small platysma doses can enhance the lift and satisfaction without notable extra side effects. 3
  • Setting expectations

    • Lift is subtle but noticeable in photos and at rest. Some patients perceive the change as modest; retreatment every 3–4 months maintains results. 6
  • Why precision matters most

    • Live ultrasound studies show the DAO’s location and depth vary; blind “landmark-only” injections risk reduced effect or side effects. Ultrasound-guided, lower-DAO placement is the most evidence-based, predictable approach today. 4, 2, 3, 1

Related Questions

What are the contraindications, recommended dosing regimens, administration techniques, and safety monitoring for botulinum toxin type A in cosmetic and therapeutic applications?
Can I receive a Botox (botulinum toxin) touch‑up injection three weeks after the initial treatment?
What are the most common correctable facial wrinkles that can be treated with botulinum toxin type A (Botox)?
What are the contraindications, recommended dosing, injection intervals, and safety precautions for onabotulinumtoxinA (Botox) injections in cosmetic facial treatment and chronic migraine?
What is the function of the depressor anguli oris (DAO) muscle and how do neuromodulators like Botox (Botulinum toxin) affect it?
Which antidiabetic medication can be prescribed for a patient with mildly elevated serum creatinine (mild renal impairment)?
How should I interpret an arterial blood gas showing normal pH, severe hypercapnia, mild hypoxemia, metabolic alkalosis, anemia, with normal lactate and ionized calcium in a patient receiving 5 L/min oxygen via an oxymask?
Can metformin be given to a patient with mildly elevated blood urea nitrogen (BUN) and serum creatinine?
Can renal failure cause benzodiazepine toxicity?
When should the carbimazole dose be reduced in a hyperthyroid patient, i.e., after free T4 and free T3 have normalized within laboratory reference ranges?
What is the significance of achieving a coronary perfusion pressure of 21 mmHg during cardiac arrest resuscitation for maintaining cerebral perfusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.